| RS1230092559 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Carcinoma of colon |
| RS1230096882 |
IDUA
|
Health Risk |
Pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS1230118868 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1230123411 |
ASNS
|
Health Risk |
Likely pathogenic |
Abnormal cerebral morphology, Abnormal cerebral morphology |
| RS1230133310 |
SYNJ1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS1230140208 |
TGM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive congenital ichthyosis 1, Lamellar ichthyosis |
| RS1230152194 |
ANO5
|
Health Risk |
Pathogenic |
— |
| RS1230192802 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1230203913 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1230207719 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1230237404 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS1230241288 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS1230243590 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1230244328 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1230271892 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS1230283665 |
VARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, Neurodevelopmental disorder with microcephaly |
| RS1230294673 |
FBXO11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS1230303971 |
CDH23
|
Health Risk |
Pathogenic |
Usher syndrome type 1D, Usher syndrome type 1 |
| RS1230328335 |
RPGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1230340692 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1230343126 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS1230351650 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Cardiovascular phenotype |
| RS1230368107 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1230382008 |
WHRN
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1230388887 |
TTC19
|
Health Risk |
Pathogenic |
— |
| RS1230407213 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS1230429863 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Alstrom syndrome |
| RS1230512934 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1230530438 |
NDUFA10
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 22 |
| RS1230532866 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1230538609 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS1230553094 |
MYH2
|
Health Risk |
Pathogenic |
— |
| RS1230558010 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 4, Autosomal recessive polycystic kidney disease |
| RS1230578718 |
COL6A3
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1230591674 |
ALDH18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant spastic paraplegia type 9, de Barsy syndrome |
| RS1230622899 |
SCN11A
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 7, Familial episodic pain syndrome with predominantly lower limb involvement |
| RS1230625396 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1230629432 |
OPA3
|
Health Risk |
Likely pathogenic |
3-Methylglutaconic aciduria type 3, Optic atrophy 3 |
| RS1230629953 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1230641631 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS1230668487 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1230674723 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1230676326 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS1230692815 |
BBS10
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Bardet-Biedl syndrome 10 |
| RS1230710158 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1230714956 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1230727136 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1230730741 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS1230741949 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS1230753352 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1230772677 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1230781262 |
PTS
|
Health Risk |
Pathogenic |
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency, 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
| RS12308034 |
ANO6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1230803568 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1230808770 |
GMPPB
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14 |
| RS1230821582 |
DSP
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic right ventricular dysplasia 8 |
| RS1230836596 |
AFG2B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hearing loss and spasticity, Neurodevelopmental disorder with hearing loss and spasticity |
| RS1230837637 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1230845897 |
UNC80
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS1230883512 |
RP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1230886860 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1230892001 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1230894568 |
NAGLU
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS1230899870 |
CHD3
|
Health Risk |
Likely pathogenic |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS1230903176 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS1230911299 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, DNAH5-related disorder |
| RS1230916222 |
SPEF2
|
Health Risk |
Pathogenic |
Spermatogenic failure 43, Spermatogenic failure 43 |
| RS1230917852 |
ALOX12B
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 2, Autosomal recessive congenital ichthyosis 2 |
| RS1230918876 |
MARS1
|
Health Risk |
Pathogenic |
— |
| RS1230919713 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS1230920104 |
ELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1230923403 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1230941179 |
JAM2
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS1230959391 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS1230995902 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1231012263 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1231016571 |
WNT10B
|
Health Risk |
Likely pathogenic |
Split hand-foot malformation 6, Split hand-foot malformation 6 |
| RS1231024778 |
WFS1
|
Health Risk |
Pathogenic |
— |
| RS1231027193 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1231036283 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1231044656 |
MED13L
|
Health Risk |
Conflicting classifications of pathogenicity |
Dextro-looped transposition of the great arteries, Dextro-looped transposition of the great arteries |
| RS1231097123 |
LMNA
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1231112953 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1231122388 |
CEP290
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 14, Joubert syndrome |
| RS1231123861 |
PNPLA1
|
Health Risk |
Pathogenic |
Congenital ichthyosiform erythroderma, Congenital ichthyosiform erythroderma |
| RS1231150660 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS1231174547 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1231186035 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1231204217 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1231208679 |
THG1L
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1231217208 |
SIX5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1231250334 |
CNGB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 45 |
| RS1231254705 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1231277831 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1231294235 |
TBR1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and speech delay, Intellectual developmental disorder with autism and speech delay |
| RS1231303606 |
SETBP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS1231305572 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1231314681 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1231321479 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 1 |
| RS1231343218 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |